"
We expect AstraZeneca to step up its efforts to distribute more and catch up. This will be the benchmark on the possibility" for the company "to export from other Member States as well."
Failure to authorize Italy "is not a one-off, it depends on the company to" recreate "trust by honoring the contract
. If it does so, the export doors will certainly be open".
Thus the president of the European Commission, Ursula von der Leyen, in an interview with a small group of European media, including ANSA
The number of vaccine doses available in the EU is expected to reach 100 million per month starting in April.
said von der Leyen in an interview with the German newspapers Stuttgarter Zeitung and Stuttgarter Nachrichten and also taken up by Politico.eu.
"From April onwards, the quantities could double again according to the manufacturers' plans, also because more vaccines are about to be approved," he said, adding that he expects "an average of about 100 million doses per month in the second quarter, for a total of 300 million by the end of June ".
"The president in her interview did not specify the" vaccine companies, "so the figures she gave are the global figures we now estimate for the second quarter. You know that the situation is evolving and that is why we are very cautious in the estimates that also evolve according to our contacts with companies ", said the spokesman of the European Commission Eric Mamer, responding to journalists who asked him whether the Johnson & Johnson vaccine was or not included in the announcement of the President of the European Commission Ursula von der Leyen on the 300 million doses by the end of June.
The Johnson & Johnson vaccine has not yet received the approval from the EMA.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/RC4B72FDDQXT46YR3YBE2AOT4A.jpg)
